Immix Biopharma, Inc.
IMMX
$1.99
-$0.42-17.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.92M | 17.68M | 19.69M | 23.98M | 29.32M |
| Total Receivables | -- | 1.97M | 1.98M | 1.98M | 2.02M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 689.70K | 509.20K | 1.05M | 1.27M | 1.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 168.40K | 32.30K | 36.50K | 105.80K | 175.20K |
| Total Current Assets | 16.78M | 20.20M | 22.76M | 27.33M | 32.92M |
|
|
|||||
| Total Current Assets | 16.78M | 20.20M | 22.76M | 27.33M | 32.92M |
| Net Property, Plant & Equipment | 3.09M | 2.73M | 2.37M | 1.48M | 1.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.40K | 20.40K | 20.40K | 20.40K | 20.40K |
| Total Assets | 19.89M | 22.95M | 25.14M | 28.84M | 34.35M |
|
|
|||||
| Total Accounts Payable | 5.74M | 5.39M | 3.29M | 2.35M | 3.51M |
| Total Accrued Expenses | 3.50M | 3.23M | 3.21M | 1.51M | 2.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 67.80K | 65.20K | 62.70K | 48.40K | 34.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.31M | 8.69M | 6.56M | 3.90M | 5.66M |
|
|
|||||
| Total Current Liabilities | 9.31M | 8.69M | 6.56M | 3.90M | 5.66M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 991.10K | 1.01M | 1.03M | 1.04M | 1.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.30M | 9.70M | 7.59M | 4.94M | 6.72M |
|
|
|||||
| Common Stock & APIC | 89.25M | 88.38M | 87.67M | 86.94M | 86.60M |
| Retained Earnings | -79.57M | -75.02M | -70.21M | -63.06M | -58.67M |
| Treasury Stock & Other | -84.50K | -101.00K | 92.10K | 17.00K | -10.30K |
| Total Common Equity | 9.59M | 13.25M | 17.55M | 23.89M | 27.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.59M | 13.25M | 17.55M | 23.89M | 27.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -283.30K |
| Total Equity | 9.59M | 13.25M | 17.55M | 23.89M | 27.63M |
|
|
|||||